The vaccine is administered by deep intramuscular injection, preferably in the anterolateral part of the thigh in children aged 2-11 months or in the area of the deltoid muscle of the shoulder in older persons.
The BEXERO vaccine is indicated for active immunization of persons aged 2 months and older against invasive meningococcal infection caused by Neisseria meningitidis serogroup B.
Hypersensitivity to the active substances or to any excipients.
Among the most common: